fr   en
Acquisitions
Select a company :
Choose date:
«      1   |   2   |   3   |   4   |   5   |   6   |   7   |   8   |   9   |   10      »      
Date Acquiring pharma company Acquired biotech company Amount Terms / other
2008-04-10 Paion (Germany) CeNeS Pharmaceuticals (UK) £10.9 million (€ 13.6 million) See details
2008-02-11 Newron Pharmaceuticals (Italy) Hunter Fleming (UK) upfront payment of €8 million
and sucsess-based milestones related to the Hunter-Feming programs will be made up to a maximum of €17 million
See details
2007-12-05 Amarin (UK) Ester Neurosciences (Israel) $32 million See details
2007-11-23 Orexo (Sweden) Biolipox (Sweden) SEK 856 million (Euro 93.1 million) See details
2007-11-06 Direvo Biotech AG (Germany) AC Biotec GmbH (Germany) Financial details were not disclosed. See details
2007-11-01 Averion International (USA) Hesperion (Switzerland) €25 million See details
2007-10-05 Wyeth (USA) Haptogen (UK) Financial details were not disclosed. See details
2007-10-05 Avesta Biotherapeutics and Research (India) Siegfried Biologics GmbH (Switzerland) The purchase price was not disclosed. See details
2007-09-25 Biolipox (Sweden) Inflazyme Pharmaceuticals (Canada) $ CAD 11 million See details
2007-09-24 Evotec (Germany) Renovis (USA) US $ 151.8 million See details
2007-07-27 ReNeuron (UK) AmCyte (USA) $ 4 millions See details
2007-06-18 Bachem (Switzerland) The Clinalfa® division of Merck Biosciences, a subsidiary of Merck KGaA The financial details of the operation have not been disclosed. See details
2007-04-23 AstraZeneca (GB) MedImmune (USA) $15.6 billion See details
2007-04-11 TopoTarget (Denmark) Apoxis (Switzerland) Euro14.5 million See details
2007-03-29 Evotec (Germany) Neuro3D (France) Euro21 million See details
«      1   |   2   |   3   |   4   |   5   |   6   |   7   |   8   |   9   |   10      »